X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (323) 323
Patent (50) 50
Publication (39) 39
Book Review (32) 32
Book Chapter (10) 10
Conference Proceeding (4) 4
Dissertation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (221) 221
humans (206) 206
hematology (133) 133
oncology (96) 96
male (79) 79
female (74) 74
middle aged (73) 73
aged (64) 64
waldenstrom macroglobulinemia - drug therapy (63) 63
abridged index medicus (62) 62
rituximab (62) 62
waldenstrom macroglobulinemia - genetics (53) 53
human necessities (50) 50
hygiene (50) 50
medical or veterinary science (50) 50
adult (46) 46
preparations for medical, dental, or toilet purposes (44) 44
chemistry (43) 43
consensus panel recommendations (43) 43
metallurgy (43) 43
waldenstrom macroglobulinemia - pathology (43) 43
lymphoma (39) 39
2nd international workshop (36) 36
aged, 80 and over (35) 35
chronic lymphocytic-leukemia (34) 34
treatment outcome (34) 34
multiple-myeloma (31) 31
therapy (31) 31
waldenstrom macroglobulinemia - therapy (30) 30
bortezomib (29) 29
mutation (29) 29
antineoplastic agents - therapeutic use (28) 28
expression (28) 28
myeloid differentiation factor 88 - genetics (28) 28
myd88 (27) 27
antineoplastic combined chemotherapy protocols - therapeutic use (26) 26
waldenstrom macroglobulinemia - diagnosis (26) 26
immunoglobulin m - blood (25) 25
animals (24) 24
cancer (24) 24
heterocyclic compounds (24) 24
ibrutinib (24) 24
organic chemistry (24) 24
survival (24) 24
waldenstrom macroglobulinemia (24) 24
multiple myeloma (23) 23
multiple myeloma - pathology (23) 23
myd88 l265p (23) 23
tumor cells, cultured (23) 23
antibodies, monoclonal - therapeutic use (22) 22
antibodies, monoclonal, murine-derived (22) 22
apoptosis - drug effects (21) 21
immunoglobulin m (21) 21
mice (21) 21
waldenstrom macroglobulinaemia (21) 21
cxcr4 (20) 20
hematology, oncology and palliative medicine (20) 20
microbiology (20) 20
waldenstrom macroglobulinemia - blood (20) 20
waldenström macroglobulinemia (20) 20
apoptosis (19) 19
beer (19) 19
biochemistry (19) 19
compositions or test papers therefor (19) 19
condition-responsive control in microbiological orenzymological processes (19) 19
enzymology (19) 19
l265p somatic mutation (19) 19
measuring or testing processes involving enzymes, nucleicacids or microorganisms (19) 19
mutation or genetic engineering (19) 19
processes of preparing such compositions (19) 19
spirits (19) 19
vinegar (19) 19
waldenstrom macroglobulinemia - mortality (19) 19
wine (19) 19
signal transduction - drug effects (18) 18
waldenstrom macroglobulinemia - immunology (18) 18
waldenström macroglobulinaemia (18) 18
dexamethasone (17) 17
patients (17) 17
waldenstrom macroglobulinemia - metabolism (17) 17
cell line, tumor (16) 16
disease progression (16) 16
disease-free survival (16) 16
international workshop (16) 16
lymphoplasmacytic lymphoma (16) 16
macroglobulinemia (16) 16
prognosis (16) 16
receptors, cxcr4 - genetics (16) 16
activation (15) 15
multiple myeloma - metabolism (15) 15
somatic mutation (15) 15
leukemia (14) 14
multiple myeloma - drug therapy (14) 14
specific therapeutic activity of chemical compounds ormedicinal preparations (14) 14
antibodies, monoclonal - administration & dosage (13) 13
multiple-myeloma cells (13) 13
myd88 protein (13) 13
recommendations (13) 13
waldenstrom's macroglobulinemia (13) 13
antineoplastic agents - pharmacology (12) 12
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


New England Journal of Medicine, ISSN 0028-4793, 08/2015, Volume 373, Issue 6, pp. 584 - 586
Journal Article
Blood, ISSN 0006-4971, 08/2015, Volume 126, Issue 6, pp. 721 - 732
Waldenstrom macroglobulinemia (WM) is a B-cell neoplasm manifested by the accumulation of clonal immunoglobulin (Ig)M-secreting lymphoplasmacytic cells. MYD88... 
CONSENSUS PANEL RECOMMENDATIONS | 2ND INTERNATIONAL WORKSHOP | L265P SOMATIC MUTATION | MULTIPLE-MYELOMA | RITUXIMAB THERAPY | IMMUNOGLOBULIN-M | MYD88 L265P | LYMPHOPROLIFERATIVE DISORDERS | LYMPHOPLASMACYTIC CELLS | INHIBITOR EVEROLIMUS | HEMATOLOGY | Cyclophosphamide - administration & dosage | Nitrogen Mustard Compounds - administration & dosage | Waldenstrom Macroglobulinemia - therapy | Humans | Middle Aged | Pyrazines - administration & dosage | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Male | Transplantation, Autologous | Molecular Targeted Therapy | Waldenstrom Macroglobulinemia - pathology | Adult | Receptors, CXCR4 - genetics | B-Lymphocytes - pathology | Boronic Acids - administration & dosage | Everolimus | B-Lymphocytes - metabolism | Waldenstrom Macroglobulinemia - diagnosis | Immunoglobulin M - genetics | Gene Expression | Genetic Predisposition to Disease | Sirolimus - analogs & derivatives | Bortezomib | Pyrimidines - administration & dosage | Myeloid Differentiation Factor 88 - genetics | Antineoplastic Combined Chemotherapy Protocols | Hematopoietic Stem Cell Transplantation | Rituximab | Vidarabine - analogs & derivatives | Cladribine - administration & dosage | Plasmapheresis | Receptors, CXCR4 - metabolism | B-Lymphocytes - drug effects | Sirolimus - administration & dosage | Pyrazoles - administration & dosage | Bendamustine Hydrochloride | Aged | Oligopeptides - administration & dosage | Vidarabine - administration & dosage | Myeloid Differentiation Factor 88 - metabolism | Waldenstrom Macroglobulinemia - genetics | Index Medicus | Abridged Index Medicus
Journal Article
Hematology/Oncology Clinics of North America, ISSN 0889-8588, 10/2018, Volume 32, Issue 5, pp. xiii - xiv
Journal Article
American Journal of Hematology, ISSN 0361-8609, 08/2018, Volume 93, Issue 8, pp. E201 - E202
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2015, Volume 373, Issue 6, pp. 584 - 586
Journal Article
The Lancet Haematology, ISSN 2352-3026, 07/2018, Volume 5, Issue 7, pp. e275 - e276
Journal Article
British Journal of Haematology, ISSN 0007-1048, 02/2018, Volume 180, Issue 3, p. 374
Summary MYD88 mutations are present in 95% of Waldenstrom Macroglobulinaemia (WM) patients, and support diagnostic discrimination from other IgM-secreting... 
Immunoglobulin M | Transformation | Cell survival | Multiple myeloma | Multivariate analysis | Lymphoma | Patients | Survival | Confidence intervals | Discrimination | Lymphocytes B | MyD88 protein | Differential diagnosis | Diagnostic systems | Mutation | Diagnosis | B-cell lymphoma
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 12/2012, Volume 367, Issue 23, pp. 2256 - 2257
Journal Article
American Journal of Hematology, ISSN 0361-8609, 10/2016, Volume 91, Issue 10, pp. 1032 - 1035
Journal Article
American Journal of Hematology, ISSN 0361-8609, 06/2016, Volume 91, Issue 6, pp. E312 - E313
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2012, Volume 367, Issue 9, pp. 826 - 833
Journal Article
Hematological Oncology, ISSN 0278-0232, 06/2013, Volume 31, Issue S1, pp. 76 - 80
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 04/2015, Volume 372, Issue 15, pp. 1430 - 1440
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.